Topics

Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk

16:12 EST 13 Feb 2020 | STAT

The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in…

Original Article: Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk

NEXT ARTICLE

More From BioPortfolio on "Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...